198 related articles for article (PubMed ID: 11966546)
21. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
Katoh M; Asaka M; Kudoh M; Kagaya H; Katagiri M; Takeda H
J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324
[TBL] [Abstract][Full Text] [Related]
22. Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients.
Vetvik K; Schrumpf E; Mowinckel P; Aase S; Andersen KJ
Scand J Gastroenterol; 1994 Nov; 29(11):995-1000. PubMed ID: 7871380
[TBL] [Abstract][Full Text] [Related]
23. Increasing biopsy number and sampling from gastric body improve the sensitivity of rapid urease test in patients with peptic ulcer bleeding.
Lee TH; Lin CC; Chung CS; Lin CK; Liang CC; Tsai KC
Dig Dis Sci; 2015 Feb; 60(2):454-7. PubMed ID: 25213078
[TBL] [Abstract][Full Text] [Related]
24. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
25. Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group.
Cloud ML; Enas N; Humphries TJ; Bassion S
Dig Dis Sci; 1998 May; 43(5):993-1000. PubMed ID: 9590413
[TBL] [Abstract][Full Text] [Related]
26. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage.
Lai KC; Hui WM; Wong BC; Hu WH; Lam SK
Aliment Pharmacol Ther; 2000 Aug; 14(8):1071-6. PubMed ID: 10930902
[TBL] [Abstract][Full Text] [Related]
27. Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori-positive peptic ulcer patients.
Yamamoto S; Kaneko H; Konagaya T; Mori S; Kotera H; Hayakawa T; Yamaguchi C; Uruma M; Kusugami K; Mitsuma T
Helicobacter; 2001 Jun; 6(2):136-45. PubMed ID: 11422469
[TBL] [Abstract][Full Text] [Related]
28. Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection.
Hazell SL; Mitchell HM; Hanna G; Daskalopoulos G
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):530-2. PubMed ID: 9272389
[TBL] [Abstract][Full Text] [Related]
29. Effects of Helicobacter pylori Infection on gastric mucin expression.
Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286
[TBL] [Abstract][Full Text] [Related]
30. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A
J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322
[TBL] [Abstract][Full Text] [Related]
31. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa.
Tatsuguchi A; Miyake K; Gudis K; Futagami S; Tsukui T; Wada K; Kishida T; Fukuda Y; Sugisaki Y; Sakamoto C
Am J Gastroenterol; 2004 Nov; 99(11):2121-7. PubMed ID: 15554990
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication.
Park SM; Park J; Chang SK; Yoo BC; Kim HJ
Korean J Intern Med; 1996 Jan; 11(1):1-8. PubMed ID: 8882471
[TBL] [Abstract][Full Text] [Related]
33. [Effect of preceding acid-reducing therapy on the Helicobacter pylori eradication rate in patients with ulcerous disease].
Shcherbinina MB; Khasilev OI
Lik Sprava; 2004; (1):29-31. PubMed ID: 17051708
[TBL] [Abstract][Full Text] [Related]
34. Effect of lansoprazole on peptic ulcers.
Ohashi T; Sakata J; Haraguchi Y; Eto T
J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350
[TBL] [Abstract][Full Text] [Related]
35. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
36. Age-dependent eradication of Helicobacter pylori with dual therapy.
Treiber G; Ammon S; Klotz U
Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
[TBL] [Abstract][Full Text] [Related]
37. Association of antral mucosal levels of interleukin 8 and reactive oxygen radicals in patients infected with Helicobacter pylori.
Zhang QB; Dawodu JB; Husain A; Etolhi G; Gemmell CG; Russell RI
Clin Sci (Lond); 1997 Jan; 92(1):69-73. PubMed ID: 9038594
[TBL] [Abstract][Full Text] [Related]
38. Role of elastase and active oxygen species in gastric mucosal injury induced by aspirin administration in Helicobacter pylori-infected Mongolian gerbils.
Yoshida N; Sugimoto N; Ochiai J; Nakamura Y; Ichikawa H; Naito Y; Yoshikawa T
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():191-7. PubMed ID: 11966541
[TBL] [Abstract][Full Text] [Related]
39. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies.
Dickey W; Kenny BD; McConnell JB
Aliment Pharmacol Ther; 1996 Jun; 10(3):289-93. PubMed ID: 8791953
[TBL] [Abstract][Full Text] [Related]
40. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
